Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Endocrine-Related Cancer|April 8, 2006
Emerging anti-cancer molecular mechanisms of aminobisphosphonatesMichele Caraglia, Daniele Santini, Monica Marra, et al.
Journal of Translational Medicine|April 21, 2023
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatmentConcetta Meo, Giuseppe Palma, Francesca Bruzzese, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agentsAlfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
EGF-R small inhibitors and anti-EGF-R antibodies: advantages and limits of a new avenue in anticancer therapyMichele Caraglia, Monica Marra, Giuseppina Meo, et al.
Nature Clinical Practice. Oncology|June 8, 2006
Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonatesDaniele Santini, Michele Caraglia, Bruno Vincenzi, et al.
Toxins|October 31, 2018
Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell LineSilvia Marchese, Angela Sorice, Andrea Ariano, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Cetuximab is an active treatment of metastatic and chemorefractory thymomaGiovannella Palmieri, Mirella Marino, Marco Salvatore, et al.
Cancers|February 15, 2022
Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid TumorsLaura Grumetti, Rita Lombardi, Federica Iannelli, et al.
Scientific Reports|July 12, 2018
Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancersAndrea Polo, Silvia Marchese, Giuseppina De Petro, et al.
Pageof 16